INVESTINGBiogen Beats Q4 Estimates on Strong Sales of Treatments for MS, Spinal AtrophyBy Tony OwusuJan 30, 2020 9:20 AM EST
VideoJim Cramer Puts Tom Brady, Ryan Tannehill and Philip Rivers Against StocksFeb 13, 2020 3:08 PM EST
PRESS RELEASESXTANDI® (enzalutamide) Demonstrates Significant Improvement In Overall Survival In Phase 3 PROSPER Trial Of Patients With NmCRPCBy PR NewswireFeb 11, 2020 8:00 AM EST
PRESS RELEASESPfizer Receives Positive CHMP Opinion For Oncology Biosimilar, RUXIENCE™ (rituximab)By Business WireJan 31, 2020 9:00 AM EST
INVESTINGBiogen Beats Q4 Estimates on Strong Sales of Treatments for MS, Spinal AtrophyBy Tony OwusuJan 30, 2020 9:20 AM EST
PRESS RELEASESMelanie Ivarsson, Ph.D. Joins Moderna As Chief Development OfficerBy Business WireJan 30, 2020 8:00 AM EST
INVESTINGPfizer Is a Buying Opportunity After Earnings WhiffBy Jonas ElmerrajiJan 28, 2020 11:55 AM EST
MARKETSStocks End Higher as Wall Street Rebounds From SelloffBy Joseph WoelfelJan 28, 2020 2:44 PM EST
MARKETSApple, Coronavirus, AMD, Boeing and Nike - 5 Things You Must Know TuesdayBy Joseph WoelfelJan 28, 2020 7:14 AM EST
MARKETSStocks Post Worst Day of Year as Spreading Coronavirus Makes Wall Street JitteryBy Joseph WoelfelJan 27, 2020 2:21 PM EST
MARKETSCoronavirus, Dow Futures Plunge, Google and Kobe Bryant - 5 Things You Must Know MondayBy Joseph WoelfelJan 27, 2020 6:18 AM EST
PRESS RELEASESPfizer Vaccines Launches Global Centers Of Excellence Network To Conduct Real-World Research On Vaccine-Preventable Diseases Affecting AdultsBy Business WireJan 23, 2020 10:00 AM EST
PRESS RELEASESPfizer's Greenstone And Digital Men's Health Clinic Roman Collaborate To Offer Patients Remote Access To The Only FDA-Approved Authorized Generic Version Of Viagra® (sildenafil Citrate)By Business WireJan 23, 2020 6:45 AM EST
JIM CRAMERUsing Technical Analysis: Cramer's 'Mad Money' Recap (Friday 1/17/20)By Scott RuttJan 17, 2020 7:00 PM EST
PRESS RELEASESInsilico Enters Into Research Collaboration With Pfizer Inc. To Explore Novel Data And Artificial Intelligence System For Potential Therapeutic TargetsBy PR NewswireJan 14, 2020 8:30 AM EST
JIM CRAMERThe Language of Wall Street: Cramer's 'Mad Money' Recap (Thursday 1/2/20)By Scott RuttJan 2, 2020 7:18 PM EST
STOCKSDow Jones Stock Market Losers Starting 2020 With a HangoverBy Danny PetersonJan 2, 2020 1:11 PM EST
INVESTINGWhat Is a Payout Ratio and How Do You Calculate It?By Brian O'ConnellDec 30, 2019 6:41 PM EST
STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
MARKETSDow, S&P 500 and Nasdaq Again Finish at Record Closing HighsBy Rob LenihanNov 27, 2019 4:17 PM EST
